title: Peaking time of creatine-kinase MB in patients treated with urokinase or conventionally during acute myocardial infarction: is it really a clue to reperfusion?
authors.forename: C
authors.initials: C
authors.lastname: Brunelli
authors.forename: P
authors.initials: P
authors.lastname: Spallarossa
authors.forename: G
authors.initials: G
authors.lastname: Ghigliotti
authors.forename: M
authors.initials: M
authors.lastname: Iannetti
authors.forename: M T
authors.initials: MT
authors.lastname: Fusaro
authors.forename: S
authors.initials: S
authors.lastname: Tondi
authors.forename: M
authors.initials: M
authors.lastname: Traina
authors.forename: E
authors.initials: E
authors.lastname: Hoffmann
authors.forename: G L
authors.initials: GL
authors.lastname: Morgagni
authors.forename: L
authors.initials: L
authors.lastname: De Biase
mesh_terms: D000368:Aged; D004796:Clinical Enzyme Tests; D002986:Clinical Trials as Topic; D003402:Creatine Kinase / Q000097:blood*; D005260:Female; D006801:Humans; D007527:Isoenzymes; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis / Q000188:drug therapy*; D015425:Myocardial Reperfusion; D011897:Random Allocation; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D007527:Isoenzymes; D003402:Creatine Kinase; D014568:Urokinase-Type Plasminogen Activator